Market research
HNL.F Dr. Hönle AG
F EUR Industrials
Latest close
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 47M
- P/E ratio
- Not available
- Analyst target
- 16.3333
- Dividend yield
- Not available
- Beta
- 1.48
Profile
Company facts
- Exchange
- F
- Currency
- EUR
- Sector
- Industrials
- Industry
- Electrical Equipment & Parts
- ISIN
- DE0005157101
- Market cap
- 47M
- P/E ratio
- Not available
- Analyst target
- 16.3333
- Dividend yield
- Not available
- Beta
- 1.48
About
About Dr. Hönle AG
Hoenle AG develops, manufactures, and distributes industrial UV technologies and systems in Germany and internationally. It operates through three segments: Adhesive Systems, Curing, and Disinfection. The Adhesives Systems segment offers industrial adhesives, as well as supplies adhesive curing systems used for consumer electronics, automotive, optics and opto-electronics, and curing of adhesives applications. The Curing segment sells equipment for surface drying and curing paints, varnishes, and other coatings for printing, packaging printing, coating, and printing on three dimensional objects industries. The Disinfection segment is involved in activities in the areas of industrial water, surface, and air disinfection, including microbiological testing for various applications comprising disinfection in food industry, special lamps for life science, custom lamps, and microbiologic analyses. It serves aerospace, automotive, consumer electronics, environmental, food, health and medical technology, print, and semiconductor industries. The company was formerly known as Dr. Hönle AG and changed its name to Hoenle AG. The company was founded in 1976 and is headquartered in Gilching, Germany.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the HNL.F discussion.
5 years, 5 months ago
Dr. Hönle AG is currently in a long term downtrend where the price is trading 7.4% below its 200 day moving average.
From a valuation standpoint, the stock is 82.1% cheaper than other stocks from the Industrials sector with a price to sales ratio of 2.8.
Dr. Hönle AG's total revenue rose by 4.6% to $27M since the same quarter in the previous year.
Its net income has dropped by 37.2% to $2M since the same quarter in the previous year.
Finally, its free cash flow grew by 29.8% to $-4M since the same quarter in the previous year.
Based on the above factors, Dr. Hönle AG gets an overall score of 3/5.